Citations (39)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (15)
Adriana Guzman-Holst, Eliana de Barros, Pilar Rubio, Rodrigo DeAntonio, Otavio Cintra & Ariane Abreu. (2022) Impact after 10-year use of pneumococcal conjugate vaccine in the Brazilian national immunization program: an updated systematic literature review from 2015 to 2020. Human Vaccines & Immunotherapeutics 18:1.
Read now
Read now
Patricia Izurieta & Javier Nieto Guevara. (2022) Exploring the evidence behind the comparable impact of the pneumococcal conjugate vaccines PHiD-CV and PCV13 on overall pneumococcal disease. Human Vaccines & Immunotherapeutics 18:1.
Read now
Read now
Shahrul Mt-Isa, Lauren A. Abderhalden, Luwy Musey & Thomas Weiss. (2022) Matching-adjusted indirect comparison of pneumococcal vaccines V114 and PCV20. Expert Review of Vaccines 21:1, pages 115-123.
Read now
Read now
Jorge A. Gomez, Diana Caceres & Edisson Rodriguez. (2022) Budget impact analysis of pneumococcal conjugate vaccines in Colombia. Response to letter to the editor. Expert Review of Pharmacoeconomics & Outcomes Research 22:1, pages 5-6.
Read now
Read now
Abiel Mascareñas de Los Santos, Miguel Angel Rodríguez-Weber, Pedro Sánchez-Márquez, Magali Traskine, Roberto Carreño-Manjarrez, María Yolanda Cervantes-Apolinar, Ana Strezova, Javier Ruiz-Guiñazú, Eduardo Ortega-Barria & Dorota Borys. (2020) Can two different pneumococcal conjugate vaccines be used to complete the infant vaccination series? A randomized trial exploring interchangeability of the 13-valent pneumococcal conjugate vaccine and the pneumococcal non-typeable Haemophilus influenzae protein D-conjugate vaccine. Expert Review of Vaccines 19:11, pages 995-1010.
Read now
Read now
Patricia Izurieta, Priti Bahety, Richard Adegbola, Christopher Clarke & Bernard Hoet. (2018) Public health impact of pneumococcal conjugate vaccine infant immunization programs: assessment of invasive pneumococcal disease burden and serotype distribution. Expert Review of Vaccines 17:6, pages 479-493.
Read now
Read now
Javier Nieto Guevara, Patricia Izurieta & Bernard Hoet. (2018) Response to: Pneumococcal conjugate vaccines in Latin America: are PCV10 and PCV13 similar in terms of protection against serotype 19A?. Expert Review of Vaccines 17:4, pages 283-284.
Read now
Read now
Michael E. Pichichero. (2017) Pneumococcal whole-cell and protein-based vaccines: changing the paradigm. Expert Review of Vaccines 16:12, pages 1181-1190.
Read now
Read now
Paolo Castiglia, Lorenzo Pradelli, Stefano Castagna, Veronica Freguglia, Giorgio Palù & Susanna Esposito. (2017) Overall effectiveness of pneumococcal conjugate vaccines: An economic analysis of PHiD-CV and PCV-13 in the immunization of infants in Italy. Human Vaccines & Immunotherapeutics 13:10, pages 2307-2315.
Read now
Read now
Marta Moreira, Olga Castro, Melissa Palmieri, Sofia Efklidou, Stefano Castagna & Bernard Hoet. (2017) A reflection on invasive pneumococcal disease and pneumococcal conjugate vaccination coverage in children in Southern Europe (2009–2016). Human Vaccines & Immunotherapeutics 13:6, pages 1242-1253.
Read now
Read now
Jacek Wysocki, Jerzy Brzostek, Ryszard Konior, Falko G. Panzer, Nancy A. François, Sudheer M. Ravula, Devayani A. Kolhe, Yue Song, Ilse Dieussaert, Lode Schuerman & Dorota Borys. (2017) Antibody persistence and immunologic memory in children vaccinated with 4 doses of pneumococcal conjugate vaccines: Results from 2 long-term follow-up studies. Human Vaccines & Immunotherapeutics 13:3, pages 661-675.
Read now
Read now
Lijoy Varghese, Bruce Mungall, Xu-Hao Zhang & Bernard Hoet. (2016) Response to Wu et al. — Cost-effectiveness analysis of infant pneumococcal vaccination in Malaysia and Hong Kong. Human Vaccines & Immunotherapeutics 12:10, pages 2675-2680.
Read now
Read now
M. Nadeem Khan, Dabin Ren, Ravinder Kaur, Saleem Basha, Robert Zagursky & Michael E. Pichichero. (2016) Developing a vaccine to prevent otitis media caused by nontypeable Haemophilus influenzae. Expert Review of Vaccines 15:7, pages 863-878.
Read now
Read now
William P Hausdorff & William P Hanage. (2016) Interim results of an ecological experiment — Conjugate vaccination against the pneumococcus and serotype replacement. Human Vaccines & Immunotherapeutics 12:2, pages 358-374.
Read now
Read now
Sittana Elshafie & Saad J Taj-Aldeen. (2016) Emerging resistant serotypes of invasive Streptococcus pneumoniae. Infection and Drug Resistance 9, pages 153-160.
Read now
Read now
Articles from other publishers (24)
Carlos Rodrigo & Maria Méndez. (2021) Impact of pneumococcal vaccination on clinical forms of invasive Streptococcus pneumoniae infection in pediatrics population. Enfermedades infecciosas y microbiologia clinica (English ed.) 39:10, pages 483-485.
Crossref
Crossref
Carlos Rodrigo & Maria Méndez. (2021) Impact of pneumococcal vaccination on clinical forms of invasive Streptococcus pneumoniae infection in pediatrics population. Enfermedades Infecciosas y Microbiología Clínica 39:10, pages 483-485.
Crossref
Crossref
Clara Inés Agudelo, Carlos Castañeda-Orjuela, Maria Cristina de Cunto Brandileone, Gabriela Echániz-Aviles, Samanta Cristine Grassi Almeida, María Noemí Carnalla-Barajas, Mabel Regueira, Sofia Fossati, Pedro Alarcón, Pamela Araya, Carolina Duarte, Jacqueline Sánchez, Mirna Novas, Gilda Toraño-Peraza, Misladys Rodríguez-Ortega, Gustavo Chamorro-Cortesi, Anibal Kawabata, Gabriela García-Gabarrot, Teresa Camou, Enza Spadola, Daisy Payares, Ana Lucía Andrade, José Luis Di Fabio, Elizabeth Castañeda, A Corso, Paula Gaguetti, Omar Veliz, C S Pereira, D Napoli, M A Moscoloni, M L L Silva e Guerra, S Bokermann, Lincoln S do Prado, U J Días, J C Hormazabal, B Rojas, S Castro, D Ibáñez, J Fernandez, O Sanabria, J Moreno, Z Alarcón, M K Rodriguez, A Bautista, L P Solis, D S Apaza, M A Capote, J M Feris, D Cedano, Araceli Soto-Noguerón, Maria E Velázquez-Meza, Margarita Hernández-Salgado, M E León, Minako Nagai, Liliana Rojas, M L Vega, G P Giffoni & V Félix. (2021) The direct effect of pneumococcal conjugate vaccines on invasive pneumococcal disease in children in the Latin American and Caribbean region (SIREVA 2006–17): a multicentre, retrospective observational study. The Lancet Infectious Diseases 21:3, pages 405-417.
Crossref
Crossref
Roozbeh Nayerhoda, Dongwon Park, Charles Jones, Elsa N. Bou Ghanem & Blaine A. Pfeifer. (2020) Extended Polysaccharide Analysis within the Liposomal Encapsulation of Polysaccharides System. Materials 13:15, pages 3320.
Crossref
Crossref
J.C.De Moraes, X.M. Pérez Porcuna, J. Nieto-Guevara, A. Eisman, B. Torres, J.L. Gonzalez Redondo & X. Saez-Llorens. (2020) Vaccination with conjugate vaccines against pneumococcal disease: What really matters. Vacunas (English Edition) 21:1, pages 23-40.
Crossref
Crossref
J.C. De Moraes, X.M. Pérez Porcuna, J. Nieto-Guevara, A. Eisman, B. Torres, J.L. Gonzalez Redondo & X. Saez-Llorens. (2020) Vacunación frente a la enfermedad neumocócica con vacunas conjugadas: ¿qué es lo que verdaderamente importa?. Vacunas 21:1, pages 23-40.
Crossref
Crossref
Hager, Sützl, Stefanović, Blaukopf & Schäffer. (2019) Pyruvate Substitutions on Glycoconjugates. International Journal of Molecular Sciences 20:19, pages 4929.
Crossref
Crossref
Christian M. Harding, Mohamed A. Nasr, Nichollas E. Scott, Guillaume Goyette-Desjardins, Harald Nothaft, Anne E. Mayer, Sthefany M. Chavez, Jeremy P. Huynh, Rachel L. Kinsella, Christine M. Szymanski, Christina L. Stallings, Mariela Segura & Mario F. Feldman. (2019) A platform for glycoengineering a polyvalent pneumococcal bioconjugate vaccine using E. coli as a host. Nature Communications 10:1.
Crossref
Crossref
Nicholas J. Croucher, Alessandra Løchen & Stephen D. Bentley. (2018) Pneumococcal Vaccines: Host Interactions, Population Dynamics, and Design Principles. Annual Review of Microbiology 72:1, pages 521-549.
Crossref
Crossref
Philippe De Wals. (2018) Commentary on paradoxical observations pertaining to the impact of the 13-valent pneumococcal conjugate vaccine on serotype 3 Streptococcus pneumoniae infections in children. Vaccine 36:37, pages 5495-5496.
Crossref
Crossref
Xiao Jun Wang, Ashwini Saha & Xu-Hao Zhang. (2017) Cost-effectiveness analysis of a universal mass vaccination program with a PHiD-CV 2+1 schedule in Malaysia. Cost Effectiveness and Resource Allocation 15:1.
Crossref
Crossref
Charles H. JonesGuojian ZhangRoozbeh NayerhodaMarie BeitelsheesAndrew Hill, Pooya Rostami, Yi LiBruce A. Davidson, Paul KnightIIIIII & Blaine A. Pfeifer. (2017) Comprehensive vaccine design for commensal disease progression. Science Advances 3:10.
Crossref
Crossref
Marta Moreira, Javier Nieto & Silvia Cobaleda-Avila. (2017) Respuesta a las recomendaciones de la Asociación Española de Pediatría sobre la vacuna neumocócica de 2017. Anales de Pediatría 87:3, pages 180-181.
Crossref
Crossref
Kim M. Hare, Heidi C. Smith-Vaughan, Anne B. Chang, Susan Pizzutto, Helen L. Petsky, Gabrielle B. McCallum & Amanda J. Leach. (2017) Propensity of pneumococcal carriage serotypes to infect the lower airways of children with chronic endobronchial infections. Vaccine 35:5, pages 747-756.
Crossref
Crossref
Jorge A. Gómez, Alberto Villaseñor-Sierra, Gerardo Martínez Aguilar, Roberto Carreño Manjarrez & María Y. Cervantes-Apolinar. (2016) Estimación de la Relación Costo-Efectividad de las Vacunas Neumocócicas Conjugadas Prevenar-13 y Synflorix®, Utilizadas en Los Programas de Vacunación de Población Infantil Mexicana. Value in Health Regional Issues 11, pages 76-84.
Crossref
Crossref
Andries J. van Tonder, James E. Bray, Sigríður J. Quirk, Gunnsteinn Haraldsson, Keith A. Jolley, Martin C. J. Maiden, Steen Hoffmann, Stephen D. Bentley, Ásgeir Haraldsson, Helga Erlendsdóttir, Karl G. Kristinsson & Angela B. Brueggemann. (2016) Putatively novel serotypes and the potential for reduced vaccine effectiveness: capsular locus diversity revealed among 5405 pneumococcal genomes. Microbial Genomics 2:10.
Crossref
Crossref
Yi LiMarie BeitelsheesLei FangAndrew HillMahmoud Kamal AhmadiMingfu Chen, Bruce A. Davidson, Paul KnightIIIIII, Randall J. SmithJrJrStelios T. AndreadisAnders P. Hakansson, Charles H. JonesBlaine A. Pfeifer. (2016) In situ pneumococcal vaccine production and delivery through a hybrid biological-biomaterial vector. Science Advances 2:7.
Crossref
Crossref
Yi LiAndrew HillMarie BeitelsheesShuai ShaoJonathan F. Lovell, Bruce A. Davidson, Paul R. KnightIIIIIIAnders P. Hakansson, Blaine A. PfeiferCharles H. Jones. (2016) Directed vaccination against pneumococcal disease. Proceedings of the National Academy of Sciences 113:25, pages 6898-6903.
Crossref
Crossref
Philippe De Wals, Geneviève Deceuninck & Gaston De Serres. (2016) Effectiveness of three pneumococcal conjugate vaccines to prevent invasive pneumococcal disease in Quebec, Canada. Vaccine 34:18, pages 2053-2054.
Crossref
Crossref
J. Nieto Guevara & M.L. Carrasco. (2016) ¿Puede la inclusión de serotipos traducirse a protección?. Vacunas 17:1, pages 35-36.
Crossref
Crossref
Andries J. van Tonder, James E. Bray, Lucy Roalfe, Rebecca White, Marta Zancolli, Sigríður J. Quirk, Gunnsteinn Haraldsson, Keith A. Jolley, Martin C. J. Maiden, Stephen D. Bentley, Ásgeir Haraldsson, Helga Erlendsdóttir, Karl G. Kristinsson, David Goldblatt & Angela B. Brueggemann. (2015) Genomics Reveals the Worldwide Distribution of Multidrug-Resistant Serotype 6E Pneumococci. Journal of Clinical Microbiology 53:7, pages 2271-2285.
Crossref
Crossref
Makoto Shiragami, Akiko Mizukami, Oscar Leeuwenkamp, Tomas Mrkvan, Emmanuelle Delgleize, Yuichi Kurono & Satoshi Iwata. (2015) Reply to Farkouh RA et al. Comment on “Cost-Effectiveness Evaluation of the 10-Valent Pneumococcal Non-Typeable Haemophilus Influenzae Protein D Conjugate Vaccine and 13-Valent Pneumococcal Vaccine in Japanese Children”. Infectious Diseases and Therapy 4:2, pages 235-244.
Crossref
Crossref
Makoto Shiragami, Akiko Mizukami, Oscar Leeuwenkamp, Tomas Mrkvan, Emmanuelle Delgleize, Yuichi Kurono & Satoshi Iwata. (2014) Cost-Effectiveness Evaluation of the 10-Valent Pneumococcal Non-typeable Haemophilus influenzae Protein D Conjugate Vaccine and 13-Valent Pneumococcal Vaccine in Japanese Children. Infectious Diseases and Therapy 4:1, pages 93-112.
Crossref
Crossref
Yagob Almazrou, Atef M. Shibl, Riyadh Alkhlaif, Jean-Yves Pirçon, Sameh Anis, Walid Kandeil & William P. Hausdorff. (2015) Epidemiology of invasive pneumococcal disease in Saudi Arabian children younger than 5 years of age. Journal of Epidemiology and Global Health 6:2, pages 95.
Crossref
Crossref